A NONCYTOTOXIC SUPPRESSOR OF IMMUNOGLOBULIN-SYNTHESIS AND SECRETION BY B-CELLS OF NORMAL HUMANS AND PATIENTS WITH RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS

被引:0
|
作者
RICHTER, M
KAPLAN, H
KRAAG, G
TALOR, E
JODOUIN, CA
机构
[1] Department of Pathology and Microbiology/Immunology, Faculty of Medicine, Ottawa, ON
[2] Department of Chemistry, University of Ottawa, Ottawa, ON
[3] The Immunology Laboratory, Ottawa, ON
[4] The Division of Rheumatology, Department of Medicine, Ottawa Civic Hospital, Ottawa, ON
[5] Department of Immunology and Infectious Diseases, School of Hygiene, The Johns Hopkins University, Baltimore, MD, 21205
关键词
SUPPRESSION OF IMMUNOGLOBULIN SYNTHESIS; SUPPRESSION OF AUTOANTIBODY SYNTHESIS; HUMAN; NONTOXIC SUPPRESSOR FACTOR;
D O I
10.3109/08916939109035141
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
A factor secrected by thymocytes of immunized rabbits totally suppressed both the initiation of, and ongoing synthesis and secretion of, lectin (PWM)-induced synthesis of IgM and IgG immunoglobulins by the circulating B lymphocytes of normal humans, and of twenty consecutive patients with rheumatoid arthritis and twelve consecutive patients with systemic lupus erythematosus. The suppressor factor, referred to as human Ig synthesis/secretion suppressor factor or HISSF, is not HLA restricted in its activity and is not cytotoxic to the circulating human mononuclear cells (B cells, T cells. Null cells and monocytes). It was demonstrated that T cells precultured with HISSF were transformed into suppressor cells which, when added to fresh cultures of autologous B cells, suppressed the synthesis and secretion of IgM and IgG. On the basis of its suppressive and non-cytotoxic properties in vitro, HISSF may be an effective immunosuppressant in the treatment of patients with autoimmune diseases. © 1991 Informa UK Ltd All rights reserved: reproduction in whole or part not permitted.
引用
收藏
页码:107 / 117
页数:11
相关论文
共 50 条
  • [31] NUTRITIONAL-STATUS IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    BROWN, GMM
    KALLA, AA
    MEYERS, OL
    KOTZE, T
    SOUTH AFRICAN MEDICAL JOURNAL, 1988, 74 (06): : 296 - 297
  • [32] A SEARCH FOR RETROVIRUS INFECTION IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS
    PELTON, BK
    NORTH, M
    PALMER, RG
    HYLTON, W
    SMITHBURCHNELL, C
    SINCLAIR, AL
    MALKOVSKY, M
    DALGLEISH, AG
    DENMAN, AM
    ANNALS OF THE RHEUMATIC DISEASES, 1988, 47 (03) : 206 - 209
  • [33] STUDY OF LYMPHOCYTE POPULATIONS IN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    ARIS, H
    CARVALLO, A
    ROJAS, C
    BEKAVAC, J
    VALENZUELA, M
    RUIZ, F
    PARRA, MA
    PEREZ, L
    VARAS, MA
    CHIELD, R
    SILVA, M
    GALAZ, E
    REVISTA MEDICA DE CHILE, 1981, 109 (04) : S10 - S10
  • [34] THE DEFINITION FOR COEXISTENT RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS - REPLY
    SATOH, M
    AJMANI, AK
    AKIZUKI, M
    LUPUS, 1995, 4 (02) : 167 - 168
  • [35] CLINICAL AND IMMUNOLOGICAL FEATURES OF RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    MIKUNIS, RI
    KOZLOVA, TV
    TERAPEVTICHESKII ARKHIV, 1983, 55 (07) : 46 - 49
  • [36] COMPLICATIONS OF CYTOTOXIC AGENTS IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS
    APTEKAR, RG
    STEINBERG, AD
    DECKER, JL
    ARTHRITIS AND RHEUMATISM, 1973, 16 (04): : 533 - 533
  • [38] REGARDING THE ASSOCIATION BETWEEN RHEUMATOID-ARTHRITIS AND SYSTEMIC LUPUS-ERYTHEMATOSUS
    SOLE, JMN
    GARCIA, JV
    SACANELL, AR
    MINGUEZ, CC
    REVISTA CLINICA ESPANOLA, 1989, 184 (04): : 209 - 209
  • [39] PLEURAL FLUID COMPLEMENT IN SYSTEMIC LUPUS-ERYTHEMATOSUS AND RHEUMATOID-ARTHRITIS
    HUNDER, GG
    MCDUFFIE, FC
    HEPPER, NGG
    ANNALS OF INTERNAL MEDICINE, 1972, 76 (03) : 357 - +
  • [40] SYSTEMIC LUPUS-ERYTHEMATOSUS, RHEUMATOID-ARTHRITIS AND HLA PHENOTYPES IN JAMAICANS
    SMIKLE, MF
    BARTON, EN
    DECEULAER, K
    WILLIAMS, WN
    JAMES, OB
    WEST INDIAN MEDICAL JOURNAL, 1995, 44 (01): : 11 - 13